Prognostic Significance of Immunohistochemical Expression of EGFR and C-erbB-2 Oncoprotein in Curatively Resected Gastric Cancer
Hong Suk Song, Young Rok Do, In Ho Kim, Soo Sang Sohn, Kun Young Kwon
Cancer Res Treat. 2004;36(4):240-245.   Published online 2004 Aug 31     DOI: https://doi.org/10.4143/crt.2004.36.4.240
Citations to this article as recorded by Crossref logo
Human epidermal growth factor receptor-2 gene expression positivity determined by silver in situ hybridization/immunohistochemistry methods and associated factors in a cohort of Sri Lankan patients with gastric adenocarcinoma: a prospective study
Duminda Subasinghe, Nathan Acott, Pasyodun Koralage Buddhika Mahesh, Sivasuriya Sivaganesh, Sithum Munasinghe, Mariyan Priyanthi Kumarasinghe, Dharmabandu Nandaveva Samarasekera, Menaka Dilani Samarawickrema Lokuhetty
Journal of International Medical Research.2023; 51(2): 030006052311544.     CrossRef
Deep muscularis propria tumor invasion without lymph node metastasis as a unique subclassification of stage IB gastric cancer: a retrospective study
Kang He, Cheng Chen, Lei Xia, Lixiang Si, Xiaohua Pan, Zijian Sun, Yajing Wang, Yingying Jiang, Yue Shi, Bin Zhou, Shuaiyu Wang, Jing Han, Bo Shen, Guoren Zhou, Jianwei Lu, Xiaohua Wang
BMC Gastroenterology.2022;[Epub]     CrossRef
Expression of HER2/c-erbB-2, EGFR protein in gastric carcinoma and its clinical significance
Guoxiong Cheng, Yijun Mei, Xiaoming Pan, Ming Liu, Suping Wu
Open Life Sciences.2019; 14(1): 119.     CrossRef
An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis
Y. Wang, L. He, Y. Cheng
Clinical and Translational Oncology.2018; 20(2): 212.     CrossRef
IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules
Nikolaos A. Afratis, Panagiotis Bouris, Spyros S. Skandalis, Hinke A. Multhaupt, John R. Couchman, Achilleas D. Theocharis, Nikos K. Karamanos
Scientific Reports.2017;[Epub]     CrossRef
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
Yu-ying Lei, Jin-yu Huang, Qiong-rui Zhao, Nan Jiang, Hui-mian Xu, Zhen-ning Wang, Hai-qing Li, Shi-bo Zhang, Zhe Sun
World Journal of Surgical Oncology.2017;[Epub]     CrossRef
The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas
Aleksandra Paliga, Horia Marginean, Basile Tessier-Cloutier, Bibianna Purgina, Derek Jonker, Esmeralda C. Marginean
American Journal of Clinical Oncology.2017; 40(6): 543.     CrossRef
Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis
Zhiqiao Zhang, Hongfeng Tang, Jixin Lin, Yunzhao Hu, Guanying Luo, Zhaowen Luo, Canchang Cheng, Peng Wang
Oncotarget.2017; 8(10): 17202.     CrossRef
Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma
Roberto de Moraes Cordts Filho, Paulo Kassab, Laura Carolina Lopez Claro, Mabel Tatty de Medeiros Fracassi, Patrícia Colombo-Souza, Daniel Kenji Fukuhara, Fábio Rodrigues Thuler, Wilson Rodrigues de Freitas Junior, Elias Jirjoss Ilias, Carlos Alberto Malh
The Scientific World Journal.2016; 2016: 1.     CrossRef
The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR
Ghasem Janbabai, Ziaeddin Oladi, Touraj Farazmandfar, Tarang Taghvaei, Farshad Naghshvar
Journal of Cancer Research and Clinical Oncology.2015; 141(11): 1945.     CrossRef
The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines
Darren Chyi-Hsiang Kong, Kenneth Yee Chew, Eng Tan, Suan Khoo
Cancer Cell International.2014; 14(1): 65.     CrossRef
Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study
K. AYDIN, S.K. OKUTUR, M. BOZKURT, I. TURKMEN, E. NAMAL, K. PILANCI, A. OZTURK, Z. AKCALI, G. DOGUSOY, O.G. DEMIR
Oncology Letters.2014; 7(1): 255.     CrossRef
Metastatic gastric cancer treatment: a little slow but worthy progress
Ozkan Kanat, Bert H. O’Neil
Medical Oncology.2013;[Epub]     CrossRef
Advanced HER2-positive gastric cancer: Current and future targeted therapies
Roberto A. Pazo Cid, Antonio Antón
Critical Reviews in Oncology/Hematology.2013; 85(3): 350.     CrossRef
The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer
Akin Atmaca, Dominique Werner, Claudia Pauligk, Kristina Steinmetz, Ralph Wirtz, Hans-Michael Altmannsberger, Elke Jäger, Salah-Eddin Al-Batran
BMC Cancer.2012;[Epub]     CrossRef
Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review
Terence C. Chua, Neil D. Merrett
International Journal of Cancer.2012; 130(12): 2845.     CrossRef
Bioinformatics analysis with graph-based clustering to detect gastric cancer-related pathways
P. Liu, X. Wang, C.H. Hu, T.H. Hu
Genetics and Molecular Research.2012; 11(3): 3497.     CrossRef
Evolving standards of care in advanced gastric cancer
Jean-Emmanuel Kurtz, Patrick Dufour
Future Oncology.2011; 7(12): 1441.     CrossRef